Zilbrysq (zilucoplan)

Zilbrysq (zilucoplan) is a prescription medicine for the treatment of adult patients with generalized myasthenia gravis (gMG) which is anti-acetylcholine receptor (AChR) antibody-positive.

Zilbrysq (zilucoplan) is approved by the FDA in the USA.

  • Disease Indications : Myasthenia Gravis
  • Usage : Subcutaneous
Medicine approved by
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Food and Drug Administration (FDA)